PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Aurora Diagnostics announced today that Bruce Walton, the company’s Executive Vice President and Chief Operating Officer (COO) since January 2015, has been promoted to President and COO.
Mr. Walton has held leadership positions of increasing responsibility with Aurora since he joined the Company in 2009. In addition to his role in heading operations that support the company’s 32 pathology practices, he has been the leader of the business development function, driving the acquisition and integration of new practices. Mr. Walton has also been instrumental in creating strategies that have shaped the company’s service portfolio, including innovative molecular/next generation assays that put Aurora Diagnostics at the leading edge of pathology today.
“I am very pleased to announce Bruce’s promotion,” said Daniel D. Crowley, Chief Executive Officer and Chairman of Aurora. “He has tremendous knowledge of the industry and Aurora’s business based on years of experience. His insights and leadership have made a positive difference in virtually every aspect of our business. His colleagues look up to and enjoy working with him, and I know they join in expressing appreciation for his leadership and extending congratulations on his promotion.”
“It has been a great privilege to work with the excellent team here at Aurora building the largest independent anatomic pathology company in the country,” Mr. Walton said. “Our success is built on teamwork and a clear focus on supporting practices with strong relationships in their local communities. I am very proud to be associated with the best pathologists in all of laboratory medicine. The team provides referring physicians with accurate, timely, and highly personalized pathology results that help patients receive the most effective treatments and the best outcomes.”
About Aurora Diagnostics
Aurora Diagnostics is the nation’s largest independent integrated oncology diagnostics company in the U.S. Its 32 community-based practices, with more than 200 board-certified pathologists, offer integrated diagnostic and personalized medicine consultations to thousands of physicians. Referring physicians include dermatologists, obstetricians and gynecologists, family practitioners, gastroenterologists, urologists, general surgeons, and oncologists. Aurora pathologists provide diagnostic opinions and work collaboratively with them to determine appropriate patient treatment options.
Aurora Diagnostics is also a leader in hospital lab management services, supporting more than 200 hospitals and surgery centers throughout the country.
Additionally, the Company's Aurora Research Institute subsidiary provides specialized pathology consultation, customized laboratory services, and access to well characterized ethically collected human biomaterials to the global research community to accelerate efforts in the area of personalized medicine, which will lead to improved patient outcomes.
For additional information regarding Aurora Diagnostics and the services it provides, please visit the company website at www.auroradx.com.